Former Biolase CEO & EVP Launch Technology4Medicine

Friday, February 22, 2008 General News J E 4
SAN CLEMENTE, Calif., Feb. 21 The former senior executivesof Biolase Technologies, Inc. announced the formation of a new company,Technology4Medicine, LLC, with a dental laser division, Lasers4Dentistry, anda laser therapy division, Technology4Therapy. Jeffrey W. Jones, the formerPresident and CEO of Biolase, and Keith G. Bateman, Biolase's former ExecutiveVice President, formed Technology4Medicine to address the advancedtechnological, clinical, training and business needs of the dental, medical,veterinary and physiotherapy communities.

"While developing the dental laser industry and growing Biolase fromapproximately $1 million to $70 million in sales and 70-80% market share, wegained extensive experience and a deep understanding of the unique clinicaland business needs of the dental community," commented Jones,Technology4Medicine CEO. "Dentists face unique challenges, both clinical andfinancial, and our combined 40 plus years of executive and field experience inthe technology, medical and dental laser markets positions Technology4Medicineand its divisions to help dentists and other medical practitioners to achievetheir goals."

"Over the coming weeks and months Technology4Medicine will be introducinga broad range of advanced technology and laser based products focused onenhancing efficiency, the quality of clinical care, the patient experience andthe bottom line of dental practices," added Bateman, Technology4MedicinePresident.

"Laser therapy has long been established and accepted as standard of careinternationally. Recently the technology and clinical applications have madesignificant breakthroughs and in the U.S. there is a growing acceptance anddemand for laser therapeutic technology to eliminate or dramatically reducepain and accelerate healing. There are many laser therapy applications andindications specific to dentistry that will allow dentists to improve clinicaloutcomes, patient care and ROI."

SOURCE Technology4Medicine, LLC


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
InfoLogix to Launch SurgiChip(TM) - A Complete Rea...
Best Practices in Early-Stage Product Commercializ...